Christopher Miles

Christopher Miles serves as the Chief Operating Officer at MedAcuity since December 2024, bringing extensive experience in leadership and technology development within the medical device industry. Prior to this role, Christopher held the position of CTO at Third Pole Therapeutics from April 2019 to December 2024, overseeing the research and development of innovative medical technology for treating cardio pulmonary diseases. Christopher has also served on the Board of Directors at Delta TM Technologies, and held senior roles at Altran, Foliage, and ESA Biosciences, demonstrating a strong background in engineering management, consulting services, and product development. Christopher holds an MS in Biomedical Engineering and a BS in Electrical Engineering from Worcester Polytechnic Institute.